Tecvayli 30 mg/3 ml
Tecvayli 30 mg/3 ml is a medicine authorised by Swissmedic under authorisation number 68747. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 22 December 2022 and the authorisation is limited until 22 June 2031. ATC code L01FX24 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68747 |
|---|---|
| Name | Tecvayli 30 mg/3 ml |
| Full name | Tecvayli 30 mg/3 ml, Injektionslösung |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FX24 |
| First authorisation | 22 December 2022 |
| Authorisation validity | 22 June 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tecvayli 30 mg/3 ml, Injektionslösung | A | 22 December 2022 |
| 2 | Tecvayli 153 mg/1.7 ml, Injektionslösung | A | 22 December 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FX24 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FX24 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Tecvayli 30 mg/3 ml authorised in Switzerland?
Yes. Tecvayli 30 mg/3 ml is authorised by Swissmedic under authorisation number 68747, data as of 01 September 2026. The authorisation is limited until 22 June 2031.
Which dispensing category does Tecvayli 30 mg/3 ml have?
Tecvayli 30 mg/3 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tecvayli 30 mg/3 ml?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.